Latest Industry Insights
Industry Insight
The Liquid Biopsy Trends Transforming Cancer Detection and Treatment
Liquid biopsy is a less invasive approach compared to traditional surgical biopsies. By collecting a simple blood sample and analyzing circulating tumor DNA (ctDNA), cancer researchers and healthcare professionals can access a myriad of information about a patient’s tumor.
Industry Insight
Electrophysiology Goes Digital
Dr Jan Dolzer, a scientist-turned-engineer that has spent his career at the leading edge of amplifier development, describes the capability of Sutter's all new digital patch clamp system
Industry Insight
How Machine Learning Can Power Drug Discovery
A recent assessment of the success of the drug development process put the percentage of phase I programs that make it to approval at 13.8%. That figure points to a crisis of attrition within the industry. Netramark, a Toronto-based start-up claim they have a machine learning-powered solution to that crisis
Industry Insight
A Solution to the 'Cocktail Party' Problem
Loud background noise doesn’t just annoy people by getting in the way of good conversation – it also affects voice activated devices. AudioTelligence, a start-up based out of Cambridge, say they have developed the world’s first digital solution to this ‘cocktail party problem’.
Industry Insight
A New Language for Biological Research
Whilst all life sciences have benefited immensely from digitization and automation in the last ten years, tools designed specifically for biologists have been somewhat scarce. London-based Synthace are aiming to change that. In this blog, we ask Synthace co-founder Chris Grant how his company's platform Antha was developed and why it has earned Synthace a “Cool Vendor of the Year” award from Gartner.
Industry Insight
Sustainability Through Innovation
With growing pressure on labs to reduce waste and improve sustainability, we spoke to the Sustainability Forum at Agilent to learn more about what the company are doing to help their customers achieve their sustainability goals.
Industry Insight
How Digital Data Management Is Transforming Next-Generation Sequencing
Next-generation sequencing has revolutionized science by significantly increasing the speed and volume of data that can be generated for a given genome. As NGS technologies have become more affordable, in-house sequencing has become more popular, shifting away from outsourced projects using service providers. In this blog, Thermo Fisher Scientific’s Karen Velardi explains how labs and users can utilize data management techniques to get the most from their NGS results.
Industry Insight
Making the Move to Continuous Bioprocessing
Bioprocessing has taken on many forms over the years. Efficiency and process economics are driving the bioprocessing industry forward, fueling a move from traditional stainless steel to single use – and now continuous.
Industry Insight
Designing Proteins Bit by Bit
Cell-Free Technology is taking a unique approach to protein technology with their BioBits initiative, which they say combines the ease of use of a digital design tool with the detailed scientific validation provided by a CRO. We catch up with Cell-Free CEO Tom Meany to discuss the new technology.
Industry Insight
Developing RNA Medicines for Rare Genetic Diseases
There are approximately 7,000 known rare diseases, however, less than 6% of these have a treatment. It is estimated that between 25–35 million Americans live with a rare disease. The company ProQR is dedicated to developing new therapeutics for patients living with untreated rare diseases. We caught up with Daniel de Boer, Chief Executive Officer at ProQR to learn more about the company’s approach to finding new treatments for rare genetic diseases.
Advertisement